Abdominal Obesity (AO) has a prevalence of 36% in northern India which is more common as compared to general obesity. As per World Health Organisation (WHO) report published in 2008, Waist Circumference (WC) and Waist to Hip Ratio (WHR) are better indicators of AO as compared to Body Mass Index (BMI) if risks of metabolic disorders like diabetes mellitus, hypertension, cardiovascular disease, etc are considered. Elevation of serum Triglycerides (TG) levels with AO further increases the risk of cardiovascular diseases. Interleukin-4 (IL-4), an inflammatory marker also influences metabolic functions that induces lipolysis, improves insulin sensitivity and thus regulate obesity. Tracking AO and biomarkers (IL-4 & lipid profile) in younger age can help to postulate the risk of above diseases in later phases of life.